Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
48 hedge funds and large institutions have $219M invested in Translate Bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 9 closing their positions.
156% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 9
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
41% more funds holding
Funds holding: 34 → 48 (+14)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $227M → $219M (-$8.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$53.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.35M |
| 3 |
BlackRock
New York
|
+$3.22M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.9M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$8.22M |
| 2 |
Citigroup
New York
|
-$6.62M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.75M |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$2.75M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
-$1.93M |
TBIO Hedge Fund Activity: Q3 2018 in Review
48 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2018, worth a combined $219M — down 3.6% from $227M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new TBIO positions and 9 closed out — a net gain of 14 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Baupost Group, adding an estimated $53.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $8.22M sold.
- 48 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2018, up from 34 in Q2 2018.
- Funds reported $219M of Translate Bio, Inc. Common Stock stock for Q3 2018, down 3.6% quarter-over-quarter.
- 23 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2018 and 9 closed out, a net change of +14 holders.
- The largest Translate Bio, Inc. Common Stock buyer in Q3 2018 was Baupost Group, an estimated $53.2M added.
- The largest Translate Bio, Inc. Common Stock seller in Q3 2018 was Deerfield Management, an estimated $8.22M sold.
Based on aggregated 13F filings for Q3 2018.